165 related articles for article (PubMed ID: 37491232)
1. FSCN1 promotes proliferation, invasion and glycolysis via the IRF4/AKT signaling pathway in oral squamous cell carcinoma.
Li L; Chen L; Li Z; Huang S; Chen Y; Li Z; Chen W
BMC Oral Health; 2023 Jul; 23(1):519. PubMed ID: 37491232
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of PER2 Promotes Tumor Progression by Enhancing Glycolysis via the Phosphatidylinositol 3-Kinase/Protein Kinase B Pathway in Oral Squamous Cell Carcinoma.
Long W; Gong X; Yang Y; Yang K
J Oral Maxillofac Surg; 2020 Oct; 78(10):1780.e1-1780.e14. PubMed ID: 32615095
[TBL] [Abstract][Full Text] [Related]
3. Overproduced CPSF4 Promotes Cell Proliferation and Invasion via PI3K-AKT Signaling Pathway in Oral Squamous Cell Carcinoma.
Zhang M; Lin H; Ge X; Xu Y
J Oral Maxillofac Surg; 2021 May; 79(5):1177.e1-1177.e14. PubMed ID: 33535057
[TBL] [Abstract][Full Text] [Related]
4. BST2 regulated by the transcription factor STAT1 can promote metastasis, invasion and proliferation of oral squamous cell carcinoma via the AKT/ERK1/2 signaling pathway.
Shan F; Shen S; Wang X; Chen G
Int J Oncol; 2023 Apr; 62(4):. PubMed ID: 36929425
[TBL] [Abstract][Full Text] [Related]
5. Elevated Expression of Zinc Finger Protein 703 Promotes Cell Proliferation and Metastasis through PI3K/AKT/GSK-3β Signalling in Oral Squamous Cell Carcinoma.
Wang H; Deng X; Zhang J; Ou Z; Mai J; Ding S; Huo S
Cell Physiol Biochem; 2017; 44(3):920-934. PubMed ID: 29176314
[TBL] [Abstract][Full Text] [Related]
6. PER1 suppresses glycolysis and cell proliferation in oral squamous cell carcinoma via the PER1/RACK1/PI3K signaling complex.
Gong X; Tang H; Yang K
Cell Death Dis; 2021 Mar; 12(3):276. PubMed ID: 33723221
[TBL] [Abstract][Full Text] [Related]
7. TRIM31 promotes the progression of oral squamous cell carcinoma through upregulating AKT phosphorylation and subsequent cellular glycolysis.
Sang SQ; Zhao YJ; Wang M; Zhong XQ; Yang ZC; Lu MM
Neoplasma; 2023 Jun; 70(3):402-415. PubMed ID: 37498068
[TBL] [Abstract][Full Text] [Related]
8. Activation of PGK1 under hypoxic conditions promotes glycolysis and increases stem cell‑like properties and the epithelial‑mesenchymal transition in oral squamous cell carcinoma cells via the AKT signalling pathway.
Zhang Y; Cai H; Liao Y; Zhu Y; Wang F; Hou J
Int J Oncol; 2020 Sep; 57(3):743-755. PubMed ID: 32705252
[TBL] [Abstract][Full Text] [Related]
9. Integrin-α5 promoted the progression of oral squamous cell carcinoma and modulated PI3K/AKT signaling pathway.
Fan QC; Tian H; Wang Y; Liu XB
Arch Oral Biol; 2019 May; 101():85-91. PubMed ID: 30909080
[TBL] [Abstract][Full Text] [Related]
10. FERMT1 knockdown inhibits oral squamous cell carcinoma cell epithelial-mesenchymal transition by inactivating the PI3K/AKT signaling pathway.
Wang X; Chen Q
BMC Oral Health; 2021 Nov; 21(1):598. PubMed ID: 34814915
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-134 inhibits tumor stem cell migration and invasion in oral squamous cell carcinomas via downregulation of PI3K-Akt signaling pathway by inhibiting LAMC2 expression.
Zhou YM; Yao YL; Liu W; Shen XM; Shi LJ; Wu L
Cancer Biomark; 2020; 29(1):51-67. PubMed ID: 32568182
[TBL] [Abstract][Full Text] [Related]
12. Increased expression of lncRNA FTH1P3 promotes oral squamous cell carcinoma cells migration and invasion by enhancing PI3K/Akt/GSK3b/ Wnt/β-catenin signaling.
Liu M; Gao X; Liu CL
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8306-8314. PubMed ID: 30556871
[TBL] [Abstract][Full Text] [Related]
13. [Expression of Tyrosine Kinase Receptor 2 in Oral Squamous Cell Carcinoma and the Effect on Cell Proliferation and Migration and Epithelial-Mesenchymal Transition Process].
Zheng M; Huang Y; Fei W; Shen Y; Nie X; Gao MY
Sichuan Da Xue Xue Bao Yi Xue Ban; 2023 Mar; 54(2):342-349. PubMed ID: 36949696
[TBL] [Abstract][Full Text] [Related]
14. circ_0004872 inhibits proliferation, invasion, and glycolysis of oral squamous cell carcinoma by sponged miR-424-5p.
Dai Y; Zhu Y; Xu H
J Clin Lab Anal; 2022 Jul; 36(7):e24486. PubMed ID: 35576499
[TBL] [Abstract][Full Text] [Related]
15.
Tang KL; Tang HY; Du Y; Tian T; Xiong SJ
Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31213575
[No Abstract] [Full Text] [Related]
16. Loss of the clock gene Per1 promotes oral squamous cell carcinoma progression via the AKT/mTOR pathway.
Yang G; Yang Y; Tang H; Yang K
Cancer Sci; 2020 May; 111(5):1542-1554. PubMed ID: 32086839
[TBL] [Abstract][Full Text] [Related]
17. Carboxylesterase 2 induces mitochondrial dysfunction via disrupting lipid homeostasis in oral squamous cell carcinoma.
Chen X; Liu Q; Chen Y; Wang L; Yang R; Zhang W; Pan X; Zhang S; Chen C; Wu T; Xia J; Cheng B; Chen X; Ren X
Mol Metab; 2022 Nov; 65():101600. PubMed ID: 36113774
[TBL] [Abstract][Full Text] [Related]
18. As a Novel Tumor Suppressor, LHPP Promotes Apoptosis by Inhibiting the PI3K/AKT Signaling Pathway in Oral Squamous Cell Carcinoma.
Liu S; Gao W; Lu Y; Zhou Q; Su R; Hasegawa T; Du J; Li M
Int J Biol Sci; 2022; 18(2):491-506. PubMed ID: 35002505
[TBL] [Abstract][Full Text] [Related]
19. Fructose-1,6-Bisphosphatase 2 Inhibits Oral Squamous Cell Carcinoma Tumorigenesis and Glucose Metabolism via Downregulation of c-Myc.
Wang L; Wang J; Shen Y; Zheng Z; Sun J
Oxid Med Cell Longev; 2022; 2022():6766787. PubMed ID: 35571245
[TBL] [Abstract][Full Text] [Related]
20. miR-186-5p inhibits the progression of oral squamous cell carcinoma by targeting ITGA6 to impair the activity of the PI3K/AKT pathway.
Chen M; Zhang J
J Oral Pathol Med; 2022 Apr; 51(4):322-331. PubMed ID: 35201653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
